Cipla informs about press release

28 Jan 2019 Evaluate

Cipla has informed about press release titled ‘Cipla receives final approval for generic version of Pfizers Depo-Provera (Medroxyprogesterone Injectable, 150mg/mL)’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1447.60 -18.45 (-1.26%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×